APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Over-The-Counter (OTC) Pet Medication

Compare research editions
View pricing & licenses

Selected research

Industry Research

Over-The-Counter (OTC) Pet Medication Industry Research Report 2026

Report ID 174021270526 December 2025133 pages

Choose your research edition.

Industry ResearchOver-The-Counter (OTC) Pet Medication Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Over-The-Counter (OTC) Pet Medication Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Over-The-Counter (OTC) Pet Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over-The-Counter (OTC) Pet Medication Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Over-The-Counter (OTC) Pet Medication Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Over-The-Counter (OTC) Pet Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Over-The-Counter (OTC) Pet Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Over-The-Counter (OTC) Pet Medication is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Over-The-Counter (OTC) Pet Medication is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Over-The-Counter (OTC) Pet Medication include Merck Animal Health, Elanco, Zoetis, Virbac, Vet's Best, Vetoquinol, Sentry, Purdue Pharma L.P. and PetIQ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Over-The-Counter (OTC) Pet Medication market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Over-The-Counter (OTC) Pet Medication Market by Company

Merck Animal Health

Elanco

Zoetis

Virbac

Vet's Best

Vetoquinol

Sentry

Purdue Pharma L.P.

PetIQ

Perrigo

Nutramax Laboratories

Mobedco-Vet

Ceva Santé Animale

Boehringer Ingelheim

Antelope Pets

Over-The-Counter (OTC) Pet Medication Segment by Type

Dogs

Cats

Others

Over-The-Counter (OTC) Pet Medication Segment by Application

Online Sales

Offline Sales

Over-The-Counter (OTC) Pet Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-The-Counter (OTC) Pet Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over-The-Counter (OTC) Pet Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-The-Counter (OTC) Pet Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Over-The-Counter (OTC) Pet Medication manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Over-The-Counter (OTC) Pet Medication by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Over-The-Counter (OTC) Pet Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Over-The-Counter (OTC) Pet Medication Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Over-The-Counter (OTC) Pet Medication Sales (Kg) of Manufacturers (2021-2026) Table 7. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Manufacturers (2021-2026) Table 8. Global Over-The-Counter (OTC) Pet Medication Revenue of Manufacturers (2021-2026) Table 9. Global Over-The-Counter (OTC) Pet Medication Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Over-The-Counter (OTC) Pet Medication Average Price (US$/g) of Manufacturers (2021-2026) Table 11. Global Over-The-Counter (OTC) Pet Medication Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Over-The-Counter (OTC) Pet Medication, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Over-The-Counter (OTC) Pet Medication, Product Type & Application Table 14. Global Over-The-Counter (OTC) Pet Medication Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Over-The-Counter (OTC) Pet Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Merck Animal Health Company Information Table 19. Merck Animal Health Business Overview Table 20. Merck Animal Health Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 21. Merck Animal Health Over-The-Counter (OTC) Pet Medication Product Portfolio Table 22. Merck Animal Health Recent Developments Table 23. Elanco Company Information Table 24. Elanco Business Overview Table 25. Elanco Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 26. Elanco Over-The-Counter (OTC) Pet Medication Product Portfolio Table 27. Elanco Recent Developments Table 28. Zoetis Company Information Table 29. Zoetis Business Overview Table 30. Zoetis Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 31. Zoetis Over-The-Counter (OTC) Pet Medication Product Portfolio Table 32. Zoetis Recent Developments Table 33. Virbac Company Information Table 34. Virbac Business Overview Table 35. Virbac Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 36. Virbac Over-The-Counter (OTC) Pet Medication Product Portfolio Table 37. Virbac Recent Developments Table 38. Vet's Best Company Information Table 39. Vet's Best Business Overview Table 40. Vet's Best Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 41. Vet's Best Over-The-Counter (OTC) Pet Medication Product Portfolio Table 42. Vet's Best Recent Developments Table 43. Vetoquinol Company Information Table 44. Vetoquinol Business Overview Table 45. Vetoquinol Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 46. Vetoquinol Over-The-Counter (OTC) Pet Medication Product Portfolio Table 47. Vetoquinol Recent Developments Table 48. Sentry Company Information Table 49. Sentry Business Overview Table 50. Sentry Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 51. Sentry Over-The-Counter (OTC) Pet Medication Product Portfolio Table 52. Sentry Recent Developments Table 53. Purdue Pharma L.P. Company Information Table 54. Purdue Pharma L.P. Business Overview Table 55. Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 56. Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Product Portfolio Table 57. Purdue Pharma L.P. Recent Developments Table 58. PetIQ Company Information Table 59. PetIQ Business Overview Table 60. PetIQ Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 61. PetIQ Over-The-Counter (OTC) Pet Medication Product Portfolio Table 62. PetIQ Recent Developments Table 63. Perrigo Company Information Table 64. Perrigo Business Overview Table 65. Perrigo Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 66. Perrigo Over-The-Counter (OTC) Pet Medication Product Portfolio Table 67. Perrigo Recent Developments Table 68. Nutramax Laboratories Company Information Table 69. Nutramax Laboratories Business Overview Table 70. Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 71. Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Product Portfolio Table 72. Nutramax Laboratories Recent Developments Table 73. Mobedco-Vet Company Information Table 74. Mobedco-Vet Business Overview Table 75. Mobedco-Vet Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Mobedco-Vet Over-The-Counter (OTC) Pet Medication Product Portfolio Table 77. Mobedco-Vet Recent Developments Table 78. Ceva Santé Animale Company Information Table 79. Ceva Santé Animale Business Overview Table 80. Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Product Portfolio Table 82. Ceva Santé Animale Recent Developments Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Product Portfolio Table 87. Boehringer Ingelheim Recent Developments Table 88. Antelope Pets Company Information Table 89. Antelope Pets Business Overview Table 90. Antelope Pets Over-The-Counter (OTC) Pet Medication Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. Antelope Pets Over-The-Counter (OTC) Pet Medication Product Portfolio Table 92. Antelope Pets Recent Developments Table 93. Global Over-The-Counter (OTC) Pet Medication Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Over-The-Counter (OTC) Pet Medication Sales by Region (2021-2026) & (Kg) Table 95. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Region (2021-2026) Table 96. Global Over-The-Counter (OTC) Pet Medication Sales by Region (2027-2032) & (Kg) Table 97. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Region (2027-2032) Table 98. Global Over-The-Counter (OTC) Pet Medication Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Region (2021-2026) Table 100. Global Over-The-Counter (OTC) Pet Medication Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Region (2027-2032) Table 102. North America Over-The-Counter (OTC) Pet Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 104. North America Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 105. North America Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Over-The-Counter (OTC) Pet Medication Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Over-The-Counter (OTC) Pet Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 109. Europe Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 110. Europe Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Over-The-Counter (OTC) Pet Medication Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Over-The-Counter (OTC) Pet Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 114. Asia Pacific Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 115. Asia Pacific Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Over-The-Counter (OTC) Pet Medication Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Over-The-Counter (OTC) Pet Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 119. South America Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 120. South America Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Over-The-Counter (OTC) Pet Medication Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2026) & (Kg) Table 124. Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country (2027-2032) & (Kg) Table 125. Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Over-The-Counter (OTC) Pet Medication Sales by Type (2021-2026) & (Kg) Table 128. Global Over-The-Counter (OTC) Pet Medication Sales by Type (2027-2032) & (Kg) Table 129. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Type (2021-2026) Table 130. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Type (2027-2032) Table 131. Global Over-The-Counter (OTC) Pet Medication Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Over-The-Counter (OTC) Pet Medication Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Type (2021-2026) Table 134. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Type (2027-2032) Table 135. Global Over-The-Counter (OTC) Pet Medication Price by Type (2021-2026) & (US$/g) Table 136. Global Over-The-Counter (OTC) Pet Medication Price by Type (2027-2032) & (US$/g) Table 137. Global Over-The-Counter (OTC) Pet Medication Sales by Application (2021-2026) & (Kg) Table 138. Global Over-The-Counter (OTC) Pet Medication Sales by Application (2027-2032) & (Kg) Table 139. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Application (2021-2026) Table 140. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Application (2027-2032) Table 141. Global Over-The-Counter (OTC) Pet Medication Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Over-The-Counter (OTC) Pet Medication Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Application (2021-2026) Table 144. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Application (2027-2032) Table 145. Global Over-The-Counter (OTC) Pet Medication Price by Application (2021-2026) & (US$/g) Table 146. Global Over-The-Counter (OTC) Pet Medication Price by Application (2027-2032) & (US$/g) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Over-The-Counter (OTC) Pet Medication Distributors List Table 150. Over-The-Counter (OTC) Pet Medication Customers List Table 151. Over-The-Counter (OTC) Pet Medication Industry Trends Table 152. Over-The-Counter (OTC) Pet Medication Industry Drivers Table 153. Over-The-Counter (OTC) Pet Medication Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Over-The-Counter (OTC) Pet Medication Product Image Figure 5. Global Over-The-Counter (OTC) Pet Medication Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Over-The-Counter (OTC) Pet Medication Market Size (2021-2032) & (US$ Million) Figure 7. Global Over-The-Counter (OTC) Pet Medication Sales (2021-2032) & (Kg) Figure 8. Global Over-The-Counter (OTC) Pet Medication Average Price (US$/g) & (2021-2032) Figure 9. Dogs Product Image Figure 10. Cats Product Image Figure 11. Others Product Image Figure 12. Online Sales Product Image Figure 13. Offline Sales Product Image Figure 14. Global Over-The-Counter (OTC) Pet Medication Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Over-The-Counter (OTC) Pet Medication, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Over-The-Counter (OTC) Pet Medication Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Over-The-Counter (OTC) Pet Medication Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Over-The-Counter (OTC) Pet Medication Sales by Region in 2025 Figure 20. Global Over-The-Counter (OTC) Pet Medication Revenue by Region in 2025 Figure 21. North America Over-The-Counter (OTC) Pet Medication Market Size by Country in 2025 Figure 22. North America Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 23. North America Over-The-Counter (OTC) Pet Medication Revenue Market Share by Country (2021-2032) Figure 24. United States Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Over-The-Counter (OTC) Pet Medication Market Size by Country in 2025 Figure 28. Europe Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 29. Europe Over-The-Counter (OTC) Pet Medication Revenue Market Share by Country (2021-2032) Figure 30. Germany Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Over-The-Counter (OTC) Pet Medication Market Size by Country in 2025 Figure 41. Asia Pacific Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Over-The-Counter (OTC) Pet Medication Revenue Market Share by Country (2021-2032) Figure 43. China Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Over-The-Counter (OTC) Pet Medication Market Size by Country in 2025 Figure 52. South America Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 53. South America Over-The-Counter (OTC) Pet Medication Revenue Market Share by Country (2021-2032) Figure 54. Brazil Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size by Country in 2025 Figure 58. Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue Market Share by Country (2021-2032) Figure 60. Egypt Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Over-The-Counter (OTC) Pet Medication Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Type (2021-2032) Figure 66. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Type (2021-2032) Figure 67. Global Over-The-Counter (OTC) Pet Medication Price (US$/g) by Type (2021-2032) Figure 68. Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Application (2021-2032) Figure 69. Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Application (2021-2032) Figure 70. Global Over-The-Counter (OTC) Pet Medication Price (US$/g) by Application (2021-2032) Figure 71. Over-The-Counter (OTC) Pet Medication Value Chain Figure 72. Over-The-Counter (OTC) Pet Medication Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Over-The-Counter (OTC) Pet Medication Industry Opportunities and Challenges

Scope & coverage.

Types
  • Dogs
  • Cats
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Merck Animal Health
  • Elanco
  • Zoetis
  • Virbac
  • Vet's Best
  • Vetoquinol
  • Sentry
  • Purdue Pharma L.P.
  • PetIQ
  • Perrigo
  • Nutramax Laboratories
  • Mobedco-Vet
  • Ceva Santé Animale
  • Boehringer Ingelheim
  • Antelope Pets

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Over-The-Counter (OTC) Pet Medication Market Size (2021-2032)
  4. 2.2.2 Global Over-The-Counter (OTC) Pet Medication Sales (2021-2032)
  5. 2.2.3 Global Over-The-Counter (OTC) Pet Medication Market Average Price (2021-2032)
  6. 2.3 Over-The-Counter (OTC) Pet Medication by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Dogs
  9. 2.3.3 Cats
  10. 2.3.4 Others
  11. 2.4 Over-The-Counter (OTC) Pet Medication by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Online Sales
  14. 2.4.3 Offline Sales
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Over-The-Counter (OTC) Pet Medication Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Over-The-Counter (OTC) Pet Medication Sales (Kg) of Manufacturers (2021-2026)
  3. 3.3 Global Over-The-Counter (OTC) Pet Medication Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Over-The-Counter (OTC) Pet Medication Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Over-The-Counter (OTC) Pet Medication Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Over-The-Counter (OTC) Pet Medication, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Over-The-Counter (OTC) Pet Medication, Product Type & Application
  8. 3.8 Global Manufacturers of Over-The-Counter (OTC) Pet Medication, Established Date
  9. 3.9 Global Over-The-Counter (OTC) Pet Medication Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Merck Animal Health
  2. 4.1.1 Merck Animal Health Company Information
  3. 4.1.2 Merck Animal Health Business Overview
  4. 4.1.3 Merck Animal Health Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Merck Animal Health Over-The-Counter (OTC) Pet Medication Product Portfolio
  6. 4.1.5 Merck Animal Health Recent Developments
  7. 4.2 Elanco
  8. 4.2.1 Elanco Company Information
  9. 4.2.2 Elanco Business Overview
  10. 4.2.3 Elanco Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Elanco Over-The-Counter (OTC) Pet Medication Product Portfolio
  12. 4.2.5 Elanco Recent Developments
  13. 4.3 Zoetis
  14. 4.3.1 Zoetis Company Information
  15. 4.3.2 Zoetis Business Overview
  16. 4.3.3 Zoetis Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Zoetis Over-The-Counter (OTC) Pet Medication Product Portfolio
  18. 4.3.5 Zoetis Recent Developments
  19. 4.4 Virbac
  20. 4.4.1 Virbac Company Information
  21. 4.4.2 Virbac Business Overview
  22. 4.4.3 Virbac Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Virbac Over-The-Counter (OTC) Pet Medication Product Portfolio
  24. 4.4.5 Virbac Recent Developments
  25. 4.5 Vet's Best
  26. 4.5.1 Vet's Best Company Information
  27. 4.5.2 Vet's Best Business Overview
  28. 4.5.3 Vet's Best Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Vet's Best Over-The-Counter (OTC) Pet Medication Product Portfolio
  30. 4.5.5 Vet's Best Recent Developments
  31. 4.6 Vetoquinol
  32. 4.6.1 Vetoquinol Company Information
  33. 4.6.2 Vetoquinol Business Overview
  34. 4.6.3 Vetoquinol Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Vetoquinol Over-The-Counter (OTC) Pet Medication Product Portfolio
  36. 4.6.5 Vetoquinol Recent Developments
  37. 4.7 Sentry
  38. 4.7.1 Sentry Company Information
  39. 4.7.2 Sentry Business Overview
  40. 4.7.3 Sentry Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Sentry Over-The-Counter (OTC) Pet Medication Product Portfolio
  42. 4.7.5 Sentry Recent Developments
  43. 4.8 Purdue Pharma L.P.
  44. 4.8.1 Purdue Pharma L.P. Company Information
  45. 4.8.2 Purdue Pharma L.P. Business Overview
  46. 4.8.3 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Purdue Pharma L.P. Over-The-Counter (OTC) Pet Medication Product Portfolio
  48. 4.8.5 Purdue Pharma L.P. Recent Developments
  49. 4.9 PetIQ
  50. 4.9.1 PetIQ Company Information
  51. 4.9.2 PetIQ Business Overview
  52. 4.9.3 PetIQ Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 PetIQ Over-The-Counter (OTC) Pet Medication Product Portfolio
  54. 4.9.5 PetIQ Recent Developments
  55. 4.10 Perrigo
  56. 4.10.1 Perrigo Company Information
  57. 4.10.2 Perrigo Business Overview
  58. 4.10.3 Perrigo Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Perrigo Over-The-Counter (OTC) Pet Medication Product Portfolio
  60. 4.10.5 Perrigo Recent Developments
  61. 4.11 Nutramax Laboratories
  62. 4.11.1 Nutramax Laboratories Company Information
  63. 4.11.2 Nutramax Laboratories Business Overview
  64. 4.11.3 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Nutramax Laboratories Over-The-Counter (OTC) Pet Medication Product Portfolio
  66. 4.11.5 Nutramax Laboratories Recent Developments
  67. 4.12 Mobedco-Vet
  68. 4.12.1 Mobedco-Vet Company Information
  69. 4.12.2 Mobedco-Vet Business Overview
  70. 4.12.3 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Mobedco-Vet Over-The-Counter (OTC) Pet Medication Product Portfolio
  72. 4.12.5 Mobedco-Vet Recent Developments
  73. 4.13 Ceva Santé Animale
  74. 4.13.1 Ceva Santé Animale Company Information
  75. 4.13.2 Ceva Santé Animale Business Overview
  76. 4.13.3 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Ceva Santé Animale Over-The-Counter (OTC) Pet Medication Product Portfolio
  78. 4.13.5 Ceva Santé Animale Recent Developments
  79. 4.14 Boehringer Ingelheim
  80. 4.14.1 Boehringer Ingelheim Company Information
  81. 4.14.2 Boehringer Ingelheim Business Overview
  82. 4.14.3 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Boehringer Ingelheim Over-The-Counter (OTC) Pet Medication Product Portfolio
  84. 4.14.5 Boehringer Ingelheim Recent Developments
  85. 4.15 Antelope Pets
  86. 4.15.1 Antelope Pets Company Information
  87. 4.15.2 Antelope Pets Business Overview
  88. 4.15.3 Antelope Pets Over-The-Counter (OTC) Pet Medication Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Antelope Pets Over-The-Counter (OTC) Pet Medication Product Portfolio
  90. 4.15.5 Antelope Pets Recent Developments
5 Global Over-The-Counter (OTC) Pet Medication Market Scenario by Region
  1. 5.1 Global Over-The-Counter (OTC) Pet Medication Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2021-2032
  3. 5.2.1 Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2021-2026
  4. 5.2.2 Global Over-The-Counter (OTC) Pet Medication Sales by Region: 2027-2032
  5. 5.3 Global Over-The-Counter (OTC) Pet Medication Revenue by Region: 2021-2032
  6. 5.3.1 Global Over-The-Counter (OTC) Pet Medication Revenue by Region: 2021-2026
  7. 5.3.2 Global Over-The-Counter (OTC) Pet Medication Revenue by Region: 2027-2032
  8. 5.4 North America Over-The-Counter (OTC) Pet Medication Market Facts & Figures by Country
  9. 5.4.1 North America Over-The-Counter (OTC) Pet Medication Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  11. 5.4.3 North America Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Over-The-Counter (OTC) Pet Medication Market Facts & Figures by Country
  16. 5.5.1 Europe Over-The-Counter (OTC) Pet Medication Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  18. 5.5.3 Europe Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Over-The-Counter (OTC) Pet Medication Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Over-The-Counter (OTC) Pet Medication Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Over-The-Counter (OTC) Pet Medication Market Facts & Figures by Country
  41. 5.7.1 South America Over-The-Counter (OTC) Pet Medication Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  43. 5.7.3 South America Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Over-The-Counter (OTC) Pet Medication Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Over-The-Counter (OTC) Pet Medication Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Over-The-Counter (OTC) Pet Medication Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Over-The-Counter (OTC) Pet Medication Sales by Type (2021-2032)
  2. 6.1.1 Global Over-The-Counter (OTC) Pet Medication Sales by Type (2021-2032) & (Kg)
  3. 6.1.2 Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Type (2021-2032)
  4. 6.2 Global Over-The-Counter (OTC) Pet Medication Revenue by Type (2021-2032)
  5. 6.2.1 Global Over-The-Counter (OTC) Pet Medication Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Over-The-Counter (OTC) Pet Medication Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Over-The-Counter (OTC) Pet Medication Sales by Application (2021-2032)
  2. 7.1.1 Global Over-The-Counter (OTC) Pet Medication Sales by Application (2021-2032) & (Kg)
  3. 7.1.2 Global Over-The-Counter (OTC) Pet Medication Sales Market Share by Application (2021-2032)
  4. 7.2 Global Over-The-Counter (OTC) Pet Medication Revenue by Application (2021-2032)
  5. 7.2.1 Global Over-The-Counter (OTC) Pet Medication Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Over-The-Counter (OTC) Pet Medication Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Over-The-Counter (OTC) Pet Medication Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Over-The-Counter (OTC) Pet Medication Value Chain Analysis
  2. 8.1.1 Over-The-Counter (OTC) Pet Medication Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Over-The-Counter (OTC) Pet Medication Production Mode & Process
  5. 8.2 Over-The-Counter (OTC) Pet Medication Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Over-The-Counter (OTC) Pet Medication Distributors
  8. 8.2.3 Over-The-Counter (OTC) Pet Medication Customers
9 Global Over-The-Counter (OTC) Pet Medication Analyzing Market Dynamics
  1. 9.1 Over-The-Counter (OTC) Pet Medication Industry Trends
  2. 9.2 Over-The-Counter (OTC) Pet Medication Industry Drivers
  3. 9.3 Over-The-Counter (OTC) Pet Medication Industry Opportunities and Challenges
  4. 9.4 Over-The-Counter (OTC) Pet Medication Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst